Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Coronavirus channel feed
J&J to restart Covid vaccine shipments to Europe as EMA adds safety warning over rare blood clots
5 years ago
FDA+
A top analyst sees Pfizer and Moderna seizing a $38B prize as safety frets sideline global vaccine players
5 years ago
Bioregnum
Covid-19 roundup: India nudges US to lift materials export ban as cases surge
5 years ago
Covid-19 roundup: Supply chain shortages lead to half the Moderna doses delivered to Canada; J&J shots paused out of concern clots would be inappropriately treated — report
5 years ago
Tillman Gerngross' Covid-19 antibody moonshot scores $336M with the help of new ace CFO. Is an IPO next?
5 years ago
Financing
J&J faces CDC advisory committee again next week to weigh Covid-19 vaccine risks
5 years ago
Covid-19 roundup: Biden invests $1.7B to address Covid variants; EU puts faith in Pfizer with new vaccine deals
5 years ago
FDA revokes EUA for Eli Lilly Covid-19 treatment
5 years ago
FDA+
Covid-19 manufacturing roundup: Moderna eyes Nexus' Wisconsin plant for vaccine boost; Catalent wraps up plant project
5 years ago
Manufacturing
Merck scraps their $425M Covid-19 drug in latest pandemic setback
5 years ago
R&D
Sponsors should flag decentralized aspects of cancer trials to prep for the post-Covid era, FDA says
5 years ago
FDA+
Exclusive interview: Peter Marks on why full Covid-19 vaccine approvals could be just months away
5 years ago
FDA+
Covid-19 roundup: Novavax shakes up leadership with two promotions and departure of CFO; Moderna, Novavax shots added to mix-and-match study in the UK
5 years ago
Moderna says Covid-19 boosters stand a fighting chance against new variants
5 years ago
R&D
Covid-19 roundup: Citing a lack of need, Gilead cuts remdesivir study; Novavax vaccine production slowed due to supply shortages
5 years ago
J&J pauses vaccine rollout as feds probe rare cases of blood clots
5 years ago
FDA+
Covid-19 roundup: AstraZeneca's Farxiga fails PhIII test; Supply deal for Eli Lilly's solo bamlanivimab officially canceled
5 years ago
IPO market continues to churn with a pair of Covid-19 biotechs seeking Nasdaq, while mitochondria-focused Reneo debuts
5 years ago
Financing
Regeneron’s Covid mAb as a prophylactic injection: Reduced risk of symptomatic infection by 81%
5 years ago
Pharma
Biden’s budget wish list: Restore the CDC, build a new NIH research center, pump in billions to end the opioid and HIV epidemics
5 years ago
EMA investigating 4 'serious cases' of blood clots following J&J vaccinations
5 years ago
FDA+
Covid-19 roundup: Lilly/Incyte's Olumiant plus remdesivir combo whiffs PhIII; France recommends mixing vaccines among younger AstraZeneca recipients
5 years ago
Covid-19 roundup: BeiGene's repurposed BTK inhibitor flops in PhII trial; Philippines suspends AstraZeneca's vaccine after EMA draws link to blood clots
5 years ago
EMA finds link between ‘very rare’ but sometimes fatal blood clots and AstraZeneca vaccine
5 years ago
FDA+
First page
Previous page
29
30
31
32
33
34
35
Next page
Last page